Hematology· Topic 6.1 Hypoproliferative anemia and disorders of heme synthesis· 6.1.7

Pernicious anemia

Pernicious anemia is autoimmune atrophic gastritis that destroys gastric parietal cells and abolishes intrinsic factor production, causing vitamin B12 malabsorption, megaloblastic macrocytic anemia, and a potentially irreversible myelopathy and neuropathy. Diagnosis rests on a low or borderline B12 with an elevated methylmalonic acid, confirmed by anti-intrinsic factor antibody, and treatment is lifelong vitamin B12 replacement.

6 min read7 practice questions8 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: autoimmune atrophic gastritis in which autoantibodies destroy gastric parietal cells, abolishing intrinsic factor production and causing vitamin B12 (cobalamin) malabsorption.

  • Epidemiology

    Most common cause of cobalamin deficiency: dietary B12 deficiency is uncommon because hepatic stores last years, so malabsorption, and pernicious anemia specifically, dominates the workup.

  • Risk factors

    Personal or family history of autoimmune disease: autoimmune thyroiditis, type 1 diabetes, vitiligo, and celiac disease cluster with pernicious anemia and should prompt case-finding.

  • Pathophysiology

    Autoimmune targeting of parietal cells: T-cell- and antibody-mediated injury destroys the acid- and intrinsic-factor-producing parietal cells of the gastric body and fundus, producing body-predominant atrophic gastritis.

  • Clinical features

    Anemia and hematologic symptoms: progressive fatigue, weakness, and pallor from a slowly developing macrocytic anemia, sometimes with "lemon-yellow" skin from combined pallor and mild jaundice.

  • Differential diagnosis

    Folate (vitamin B9) deficiency: identical megaloblastic, macrocytic anemia with hypersegmented neutrophils and elevated homocysteine, but methylmalonic acid is normal and there is no neurologic…

  • Diagnosis

    Establish cobalamin deficiency first, then confirm pernicious anemia as the cause: a serum vitamin B12 level below 200 ng/L strongly suggests deficiency, and a borderline-low level of 200 to 400 ng/L…

  • Management

    Confirm the vitamin B12 level and check folate before treating, because giving folic acid to a patient with unrecognized B12 deficiency corrects the anemia and masks the diagnosis while subacute combined degeneration continues to progress.

  • Complications

    Irreversible neurologic injury: subacute combined degeneration present for a prolonged period may not fully reverse with treatment, making early recognition critical.

  • Prognosis

    Hematologic recovery is excellent with treatment: reticulocytosis begins within days, and the anemia typically resolves over several weeks once cobalamin is adequately replaced.

  • Prevention

    No primary prevention for the autoimmune process itself; prevention targets deficiency-related complications through early detection and lifelong replacement once diagnosed.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.